BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33895205)

  • 1. Propranolol for the treatment of ulcerated infantile hemangiomas: A prospective study.
    Ji Y; Yang K; Zhou J; Zhang X; Xiang B; Jiang X; Xu X; Qiu T; Dai S; Kong F; Lu G; Qiu Q; Zhang Y; Chen S
    J Am Acad Dermatol; 2022 May; 86(5):1149-1151. PubMed ID: 33895205
    [No Abstract]   [Full Text] [Related]  

  • 2. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
    Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
    J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol for treatment of ulcerated infantile hemangiomas.
    Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
    J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.
    Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ
    J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nadolol for Infantile Hemangiomas Previously Treated with Propranolol.
    Colmenero Sendra M; Del Boz González J; Segura Palacios JM; Valladares Millán I; Eguiluz Solana M; de Troya Martín M
    Actas Dermosifiliogr; 2024 Feb; 115(2):215-217. PubMed ID: 37356545
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple pulmonary infantile hemangiomas responsive to oral propranolol.
    Galdeano F; Herón A; Moreno S; Aprea G; Meneses M; Torrelo A
    Pediatr Dermatol; 2021 Jan; 38(1):226-228. PubMed ID: 33155718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Response to oral propranolol therapy for ulcerated hemangiomas in infancy].
    Michel JL; Patural H
    Arch Pediatr; 2009 Dec; 16(12):1565-8. PubMed ID: 19892536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic infantile hemangiomas treated with oral propranolol--a case series.
    Mhanna A; Franklin WH; Mancini AJ
    Pediatr Dermatol; 2011; 28(1):39-45. PubMed ID: 21261702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol Use for Infantile Hemangiomas.
    Ryan J
    Plast Surg Nurs; 2015; 35(3):129-30. PubMed ID: 26313676
    [No Abstract]   [Full Text] [Related]  

  • 10. Propranolol for infantile hemangiomas with hyperinsulinemic hypoglycemia.
    Miyazaki T; Ozeki M; Sasai H; Ohnishi H
    Pediatr Int; 2021 Jun; 63(6):724-725. PubMed ID: 34042227
    [No Abstract]   [Full Text] [Related]  

  • 11. Propranolol for recalcitrant ulcerated hemangioma of infancy.
    Hong E; Fischer G
    Pediatr Dermatol; 2012; 29(1):64-7. PubMed ID: 21854419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient Perspectives: Propranolol for infantile hemangiomas.
    Pediatr Dermatol; 2016 Sep; 33(5):549-50. PubMed ID: 27595871
    [No Abstract]   [Full Text] [Related]  

  • 13. Ulcerated Infantile Hemangioma of the Hard Palate: Diagnostic Treatment With Oral Propranolol.
    Ishikawa K; Fujita M; Takeda T; Mitamura S; Nishio T; Funayama E; Hayashi T; Osawa M; Maeda T; Yamamoto Y; Sasaki S
    J Craniofac Surg; 2020 Sep; 31(6):e600-e602. PubMed ID: 32649551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol-induced Involution of Infantile Hemangioma.
    Gonzalez Martinez OG; Langer PD; Milman T
    Ophthalmology; 2023 Dec; 130(12):1359. PubMed ID: 37140507
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary experiences in treating infantile hemangioma with propranolol.
    Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
    Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol.
    Meyer-Mueller C; Nicholson C; Polcari I; Boull C; Maguiness S
    Pediatr Dermatol; 2022 Mar; 39(2):255-259. PubMed ID: 35178750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of infantile hemangioma after termination of propranolol treatment.
    Chang L; Ma G; Jin Y; Ye X; Qiu Y; Chen H; Yu W; Yang X; Hu X; Lin X
    Ann Plast Surg; 2014 Feb; 72(2):173-5. PubMed ID: 24406852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical propranolol therapy for infantile hemangiomas.
    Kunzi-Rapp K
    Pediatr Dermatol; 2012; 29(2):154-9. PubMed ID: 22141326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe infantile haemangioma: complications and treatment.
    Heaton P; Kennedy C; Amin S
    J Paediatr Child Health; 2014 Apr; 50(4):325, 330. PubMed ID: 24698064
    [No Abstract]   [Full Text] [Related]  

  • 20. Rare complication - skin atrophy - after systemic conservative therapy of infantile hemangioma.
    Chakhunashvili K; Kvirkvelia E; Todua N; Chakhunashvili DG
    BMC Pediatr; 2024 Feb; 24(1):138. PubMed ID: 38395819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.